All Online

1 - 7 of 7 results

Refine

Active filters

Asthma
1 CME CREDIT

This talk will focus on several common and confusing topics and scenarios that often arise in the primary care practice setting. The faculty will review an approach to patients who come into the clinic with a diagnosis of asthma for whom the clinical suspicion is low that includes spirometry and methacholine challenge interpretation. Next, the talk will cover the evidence for using long-term oxygen therapy in respiratory patients and the various oxygen delivery systems. The faculty will also discuss the approach to chronic cough when typical therapies have failed to improve systems as well as current evidence and approach to lung cancer screening. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 2/6/2020 and they are subject to change as new information is published.


0.75 CME CREDIT

In the United States, over six million children have asthma and over 130,000 children are hospitalized yearly due to asthma exacerbations. Children with difficult-to-treat and/or severe asthma have the highest morbidity and mortality. In addition to ensuring assessment and management per existing guidelines, there is a need for more precise and personalized approaches to asthma management for these patients. This includes identification of phenotypes and tailoring medication choice based on underlying pathophysiology. This talk will address the fundamentals of identifying difficult-to-treat and severe asthma patients and outline steps to create a comprehensive asthma assessment and management plan.


1 CME CREDIT

Breathe Easy: Updates on Individualized Management of Asthma

1.00 CME/MOC
1.00 AANP | 0.23 Pharmacology |

Help your patients breathe easier with practical takeaways from this session on the individualized management of asthma. You will learn to diagnose and assess asthma severity and how to implement a stepwise approach to treatment based on that severity as well as asthma subtype, phenotype or endotype, and any underlying comorbidities. Self-management strategies from faculty experts and a proper inhaler technique demonstration will empower you to make a difference in the lives of your patients with asthma.


0.75 CME CREDIT

This talk will focus on the ambulatory management of asthma in the adult. We will review the concept of asthma control (as opposed to severity) and how it is assessed. A systematic approach to achieving good asthma control, as developed by the National Asthma Education and Prevention Program, will be reviewed. In addition, we will consider novel therapeutic approaches that have been studied since the release of the last set of guidelines in 2007, including intermittent inhaled steroids in mild asthma, anticholinergic bronchodilators, bronchial thermoplasty, and anti-IL5 monoclonal antibody.


0.75 CME CREDIT

This lecture will address management of cigarette-smoking-related lung diseases, chronic bronchitis, and emphysema, and feature prevention (smoking abstinence and smoking cessation) and interventions (pharmacologic and nonpharmacologic). COPD is now the third most common cause of death in the United States. To improve care for their patients with COPD, participants will learn about diagnosing COPD, assessing its severity, and adjusting therapy according to that assessment. The speaker will also touch upon management of acute exacerbations of COPD in the ambulatory setting.


0.75 CME CREDIT

Asthma in children is all too often not well controlled. It remains one of the most common chronic illnesses you will manage in your office and one of the most frequent reasons why children are admitted to the hospital. I will discuss recent updates on managing asthma exacerbations with inhaled and oral steroids including the risks and benefits of dexamethasone. In addition, I will review the safety of using long-acting beta agonists in combination with inhaled steroids in children. I will also provide recommendations on when to consider treatment with omalizumab, one of the new asthma biological therapies, which has been approved for children as young as six years of age.


0.75 CME CREDIT

This session will focus on the diagnosis and treatment of asthma in the ambulatory setting, with an emphasis on new developments in the last year. It will cover: measurement of exhaled nitric oxide in the diagnosis and assessment of asthma, safety of long-acting beta-agonists in the treatment of asthma, use of long-acting anticholinergic bronchodilators for asthma, and novel biologic therapies for asthma. We will also review teaching the use of inhalers in asthma, including metered-dose inhalers, dry-powder inhalers, breath-actuated inhalers, and soft-mist inhalers.